Stock screener

TECH

Conviction 77HealthcareScan · Mon, Aug 10, 2026
TECH$72.14-0.21%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Vol MA14 4.03M
May 11May 28Jun 16Jul 6Jul 23Aug 10
BIO-TECHNE CorpBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.bio-techne.com
Price72.14
Change-0.21%
Gap-0.07%
Rel volume1.26×
Avg volume3.76M
Avg $ vol270.72M
SMA 2071.87
SMA 5065.21
SMA 20059.95
Price vs 50+10.63%
Price vs 200+20.33%
MA stackbullish
50/200 cross
Supertrendup · 70.93
RSI (14)71
MACD hist-0.52
MACD cross
Stoch %K / %D71 / 71
ADX (14)60
+DI / −DI36 / 9
RSI divergenceBearish
MACD divergenceBearish
ATR %+0.84%
ADR %0.43%
52w high72.29
52w low43.30
From 52w high-0.21%
Above 52w low+66.61%
New 52w highYes
SqueezeOn · 1d
Bollinger width1.49%
%B0.75
Donchian pos80.08%
Donchian high72.39
Donchian low71.14
AVWAP (52w high)72.20
vs AVWAP high-0.08%
AVWAP (52w low)65.84
vs AVWAP low+9.58%
OBV trendFlat
Chaikin MF (20)-0.05
Today vs 20d1.26×
Avg vol (14d)4.03M
Avg vol (20d)3.76M
Avg $ vol (20d)270.72M
Market cap11.29B
RS 3m (vs SPY)+36.30%
RS 6m (vs SPY)-4.35%
RS line new highNo
Trend template6/8
Technical rank74.2
1 week+0.00%
1 month+1.18%
3 months+49.17%
6 months+8.03%
1 year+43.85%
YTD+20.94%
P/E153.88
P/B5.42
P/S9.26
P/FCF44.03
EPS0.4600
Div yield0.45%
ROE3.52%
ROA2.88%
Debt/Eq0.01
Current4.49
EV/EBITDA52.31
Gross margin64.80%
Net margin6.02%
Rev growth5.23%
EPS growth-56.34%
Price target70.89
Target upside-1.73%
Analyst ratingHold
Institutional126.02%
Ent. value11.1B
Revenue311.42M
Net income51.05M
Gross profit208.29M
Free cash flow256.55M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out156.57M
Employees3.1K
ListedMon, May 8, 1989
Free float154.83M
Float %99.0%
Short interest12.12M
Days to cover2.3d
Short volume9.8%
Squeeze score31 / 100
Next earnings
EPS forecast
Last EPS vs est$0.48 vs $0.48
Last surprise0.0% beat
Setup gradeA
Conviction77 / 100
Pattern quality
Tech rank74.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance72.20
Support62.41
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TECH · 9 recent

All disclosures →
MemberSideAmount
April McClain Delaney
April McClain Delaney
house · D · MD · traded 2026-01-28
Sell$1K–$15K
April McClain Delaney
April McClain Delaney
house · MD · traded 2025-12-05
Buy$1K–$15K
April McClain Delaney
April McClain Delaney
house · D · MD · traded 2025-08-01
Sell$1K–$15K
April McClain Delaney
April McClain Delaney
house · D · MD · traded 2025-05-26
Sell$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-04-01
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Sell$1K–$15K
April McClain Delaney
April McClain Delaney
house · D · MD · traded 2025-04-09
Buy$1K–$15K
April McClain Delaney
April McClain Delaney
house · D · MD · traded 2025-04-29
Buy$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-02-25
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in TECH · 2 buys · 4 sells

InsiderSideShares
Bohnen Shane
SVP - General Counsel · Common Stock · 2026-07-23
Tax344
Bohnen Shane
SVP - General Counsel · Stock Option (Right to Buy) · 2026-07-23
Exercise448
Bohnen Shane
SVP - General Counsel · Common Stock · 2026-07-23
Exercise448
Crouse Steven C.
President - Diag & Spatial Bi · Stock Option (right to buy) · 2026-06-02
Other
Crouse Steven C.
President - Diag & Spatial Bi · Restricted Stock Units · 2026-06-02
Other
Crouse Steven C.
President - Diag & Spatial Bi · Common Stock · 2026-06-02
Tax216
Crouse Steven C.
President - Diag & Spatial Bi · Common Stock · 2026-06-02
Exercise600
Crouse Steven C.
President - Diag & Spatial Bi · Restricted Stock Units · 2026-06-02
Exercise600
Crouse Steven C.
President - Diag & Spatial Bi · Performance Restricted Stock Units · 2026-06-02
Other
Herr Amy E.
Director · Common Stock · 2026-05-08
Other

SEC filings

EDGAR filings in TECH · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.